Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

YMAB

Y mAbs Therapeutics (YMAB)

Y mAbs Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:YMAB
DateTimeSourceHeadlineSymbolCompany
01/22/20256:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:YMABY mAbs Therapeutics Inc
01/22/20256:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:YMABY mAbs Therapeutics Inc
01/22/20256:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:YMABY mAbs Therapeutics Inc
01/22/20256:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:YMABY mAbs Therapeutics Inc
01/22/20255:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:YMABY mAbs Therapeutics Inc
01/17/20253:18PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:YMABY mAbs Therapeutics Inc
01/16/20253:44PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:YMABY mAbs Therapeutics Inc
01/13/20258:21AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:YMABY mAbs Therapeutics Inc
01/10/20258:27AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:YMABY mAbs Therapeutics Inc
01/10/20258:26AMGlobeNewswire Inc.Correcting & Replacing – Y-mAbs Provides Strategic Business Update and 2025 PrioritiesNASDAQ:YMABY mAbs Therapeutics Inc
01/10/20256:35AMGlobeNewswire Inc.Y-mAbs Appoints Experienced Commercial Leader as Head of DANYELZA Business UnitNASDAQ:YMABY mAbs Therapeutics Inc
01/10/20256:05AMGlobeNewswire Inc.Y-mAbs Provides Strategic Business Update and 2025 PrioritiesNASDAQ:YMABY mAbs Therapeutics Inc
12/23/20246:30AMGlobeNewswire Inc.Y-mAbs to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:YMABY mAbs Therapeutics Inc
12/07/202411:00AMGlobeNewswire Inc.Y-mAbs Presents SADA Platform Preclinical Data and Trial in Progress Posters at the 2024 American Society Hematology (ASH) Annual MeetingNASDAQ:YMABY mAbs Therapeutics Inc
11/27/20246:35AMGlobeNewswire Inc.Y-mAbs to Participate at Citi’s 2024 Global Healthcare ConferenceNASDAQ:YMABY mAbs Therapeutics Inc
11/14/20243:32PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:YMABY mAbs Therapeutics Inc
11/08/20246:18AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:YMABY mAbs Therapeutics Inc
11/08/20245:55AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:YMABY mAbs Therapeutics Inc
11/08/20245:35AMGlobeNewswire Inc.Y-mAbs Reports Third Quarter 2024 Financial Results and Recent Corporate DevelopmentsNASDAQ:YMABY mAbs Therapeutics Inc
11/04/20247:51AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:YMABY mAbs Therapeutics Inc
11/04/20246:35AMGlobeNewswire Inc.Y-mAbs and Nobelpharma Announce Exclusive License and Distribution Agreement for DANYELZA® (naxitamab-gqgk) in JapanNASDAQ:YMABY mAbs Therapeutics Inc
10/25/20246:05AMGlobeNewswire Inc.Y-mAbs Announces Third Quarter 2024 Conference Call and WebcastNASDAQ:YMABY mAbs Therapeutics Inc
10/01/20246:05AMGlobeNewswire Inc.Y-mAbs to Participate in Upcoming Investor Conferences in OctoberNASDAQ:YMABY mAbs Therapeutics Inc
09/20/20243:16PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:YMABY mAbs Therapeutics Inc
09/20/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:YMABY mAbs Therapeutics Inc
09/17/20247:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:YMABY mAbs Therapeutics Inc
09/17/20244:24PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:YMABY mAbs Therapeutics Inc
09/13/20243:19PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:YMABY mAbs Therapeutics Inc
09/06/20246:30AMGlobeNewswire Inc.Y-mAbs Presents Neuroblastoma Research on Naxitamab and SADA PRIT Technology Platform at AACR Special Conference on Advances in Pediatric Cancer ResearchNASDAQ:YMABY mAbs Therapeutics Inc
09/03/20244:00PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:YMABY mAbs Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:YMAB